Diagnostics trailblazer Proteomics International Laboratories has inked an expanded research deal with the University of Melbourne and Royal Women’s Hospital to pinpoint its attack on endometriosis through testing.
The move sharpens the focus on its PromarkerEndo blood test for endometriosis and sets its sights on a next-generation tissue-specific test.
